Medis Laboratories SA, Tunisia
The MédiS Laboratories is a limited company under Tunisian law with a mandate to manufacture and market various generic medications. Founded in 1995, MédiS has obtained the operating license in June 1999. The first Market Authorization dates back to the month of February 2000. Currently, Médis has a large portfolio of proven products as well as a wide sales network. Médis produced nearly 200 quality products. Several other marketing authorizations have already been filed and are being processed.
Pharma Solution represents the following Medis products in the United Arab Emirates
ANTI-INFLAMMATORY / ANTI-INFLAMMATORY STEROIDAL | ||
MP-40 (methylprednisolone Sodium Succinate) 40mg | Powder for injection preparation | |
Anti-Biotics | ||
Levodis (levofloxacin) 5mg/ml | injectable solution for infusion | |
Anesthesiology / local or regional anesthesia | ||
MEDICAINE 2% AVEC ADRENALINE® | INJECTABLE SOLUTION cartridge DENTAL | |
Infectiology / Systemic Antifungal | ||
FLUKAS (Fkuconazole) 2mg/ml 50ml and 100ml | Solution for Injection | |
Blood and Haemostasis / Anticoagulants | ||
ENOXA (Enoxparine Sodium) 2000 | INJECTABLE SOLUTION | |
ENOXA (Enoxparine Sodium) 4000 L | ||
ENOXA (Enoxparine Sodium) 6000 | ||
ENOXA (Enoxparine Sodium) 8000 | ||
Neurology – Psychatrie / Multiple Sclerosis: Interferon | ||
GLITAXON (GLATIRAMER ACETATE) 20mg | Injectable solution PFS | |
Oncology / Associated Treatments | ||
ZOLEDRA (ZOLEDRONIC ACID) 4 mg/5 ml | Powder for injection preparation | |
